CD40LG and neoplasm: Alternatively, bispecific binding molecules could be generated, e.g., by fusing the hSIRPα-blocking Nbs with a tumor-opsonizing Nb and Fc moiety (34, 35) or CD40L expressed by activated T cells to bridge innate and adaptive immune responses (36).